Liraglutide and Atherothrombotic Risk in Women With PCOSLiraglutide and Atherothrombotic Risk in Women With PCOS
Does this GLP-1 receptor agonist reduce CV risk and promote weight loss in women with PCOS? BMC Endocrine Disorders
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
More News: Diabetes | Endocrinology | Health | Polycystic Ovary Syndrome | Victoza | Weight Loss | Women